283 related articles for article (PubMed ID: 11078155)
1. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
[TBL] [Abstract][Full Text] [Related]
2. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.
Zou LP; Deretzi G; Pelidou SH; Levi M; Wahren B; Quiding C; van der Meide P; Zhu J
Neuropharmacology; 2000 Jan; 39(2):324-33. PubMed ID: 10670428
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
4. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Zhu J
J Neuroimmunol; 2003 Jul; 140(1-2):97-101. PubMed ID: 12864976
[TBL] [Abstract][Full Text] [Related]
6. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
[TBL] [Abstract][Full Text] [Related]
7. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
[TBL] [Abstract][Full Text] [Related]
8. Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue.
Zou LP; Abbas N; Volkmann I; Nennesmo I; Levi M; Wahren B; Winblad B; Hedlund G; Zhu J
Neuropharmacology; 2002 Apr; 42(5):731-9. PubMed ID: 11985832
[TBL] [Abstract][Full Text] [Related]
9. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.
Bai XF; Zhu J; Zhang GX; Kaponides G; Höjeberg B; van der Meide PH; Link H
Clin Immunol Immunopathol; 1997 May; 83(2):117-26. PubMed ID: 9143372
[TBL] [Abstract][Full Text] [Related]
10. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
[TBL] [Abstract][Full Text] [Related]
11. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis.
Mausberg AK; Szepanowski F; Odoardi F; Flügel A; Kleinschnitz C; Stettner M; Kieseier BC
J Neuroinflammation; 2018 Aug; 15(1):217. PubMed ID: 30068351
[TBL] [Abstract][Full Text] [Related]
12. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy.
Moalem-Taylor G; Allbutt HN; Iordanova MD; Tracey DJ
Brain Behav Immun; 2007 Jul; 21(5):699-710. PubMed ID: 17005365
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen.
Yu S; Chen Z; Mix E; Zhu SW; Winblad B; Ljunggren HG; Zhu J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):614-22. PubMed ID: 12125740
[TBL] [Abstract][Full Text] [Related]
14. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis.
Bao L; Lindgren JU; Zhu Yu; Ljunggren HG; Zhu J
Neurobiol Dis; 2003 Feb; 12(1):73-81. PubMed ID: 12609491
[TBL] [Abstract][Full Text] [Related]
15. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin.
Zhu J; Bai XF; Mix E; Link H
Clin Immunol Immunopathol; 1997 Jul; 84(1):85-94. PubMed ID: 9191887
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide prolongs experimental autoimmune neuritis in Lewis rats.
Zhu J; Deng GM; Diab A; Zwingenberger K; Bakhiet M; Link H
Scand J Immunol; 1998 Oct; 48(4):397-402. PubMed ID: 9790310
[TBL] [Abstract][Full Text] [Related]
17. The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.
Bao L; Lindgren JU; van der Meide P; Zhu Sw; Ljunggren HG; Zhu J
Brain Pathol; 2002 Oct; 12(4):420-9. PubMed ID: 12408228
[TBL] [Abstract][Full Text] [Related]
18. IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue.
Zou LP; Ma DH; Wei L; van der Meide PH; Mix E; Zhu J
J Neurosci Res; 1999 Apr; 56(2):123-30. PubMed ID: 10494101
[TBL] [Abstract][Full Text] [Related]
19. Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
Jin T; Yu H; Wang D; Zhang H; Zhang B; Quezada HC; Zhu J; Zhu W
Immunol Lett; 2016 Mar; 171():15-25. PubMed ID: 26791957
[TBL] [Abstract][Full Text] [Related]
20. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
